Showing Latest Articles
Evolution of Long-Term Outcome of Liver Resection for Colorectal Metastases: Analysis of Actual 5-Year Survival Rates over Two Decades
Annals of Surgical Oncology, 01/09/2012
Vigano L et al. – Long–term outcome of Liver resection (LR) for colorectal liver metastases (CRLM) improved over 20 years, even in patients with negative prognostic factors, linked to hepatic recurrences reduction and increased survival after recurrence.
Methods- Data of 393 consecutive patients who underwent LR for CRLM at Mauriziano Umberto I (Turin) until June 2005 were analyzed.
- Excluding R2 resections (n = 4) or incomplete 5–year follow–up (n = 13), 376 patients were divided according to LR date into groups A (before 1995: 90 patients), B (1995–2000: 94 patients), C (2001–2005: 192).
- Group C presented increased multiple and bilobar metastases compared with combined group A and B (C vs AB: 54.7% vs 40.2%, P = 0.005; 28.1% vs 19.0%, P = 0.038, respectively), decreased metastases diameter (C vs AB: 32 vs 40 mm, P = 0.0001).
- The 5–year overall survival, calculated excluding 4 operative mortalities (group AB), increased over the years (A, 20.5%; B, 32.6%; C, 46.4%; P < 0.0001).
- Early recurrences (1 year) were not decreased, extrahepatic recurrences even increased (C vs AB: 17.2% vs 8.6%, P = 0.015).
- Recurrence–free 5–year survival improved (C vs AB: 23.4% vs 13.9%, P = 0.019) linked to decreased liver recurrences (C vs AB: 26.8% vs 37.4%, P = 0.023).
- Resection rate (59% overall for liver recurrence) increased along with 5–year survival after recurrence (A, 4.0%; B, 14.2%; C, 21.4%; P < 0.0001).
- Survival improvement was confirmed for multiple (P = 0.003) and synchronous metastases (P = 0.008), N+ tumors (P = 0.005), and in patients without chemotherapy (P = 0.001).
